Representing uncertainty: the role of cost-effectiveness acceptability curves
✍ Scribed by Elisabeth Fenwick; Karl Claxton; Mark Sculpher
- Publisher
- John Wiley and Sons
- Year
- 2001
- Tongue
- English
- Weight
- 311 KB
- Volume
- 10
- Category
- Article
- ISSN
- 1057-9230
- DOI
- 10.1002/hec.635
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Decision‐making in health care is inevitably undertaken in a context of uncertainty concerning the effectiveness and costs of health care interventions and programmes. One method that has been suggested to represent this uncertainty is the cost‐effectiveness acceptability curve. This technique, which directly addresses the decision‐making problem, has advantages over confidence interval estimation for incremental cost‐effectiveness ratios. However, despite these advantages, cost‐effectiveness acceptability curves have yet to be widely adopted within the field of economic evaluation of health care technologies. In this paper we consider the relationship between cost‐effectiveness acceptability curves and decision‐making in health care, suggest the introduction of a new concept more relevant to decision‐making, that of the cost‐effectiveness frontier, and clarify the use of these techniques when considering decisions involving multiple interventions. We hope that as a result we can encourage the greater use of these techniques. Copyright © 2001 John Wiley & Sons, Ltd.
📜 SIMILAR VOLUMES
Cost-effectiveness analysis (CEA) compares the costs and outcomes of two or more technologies. However, there is no consensus about which measure of effectiveness should be used in each analysis. Clinical researchers have to select an appropriate outcome for their purpose, and this choice can have d
Prediction of construction cost of wastewater treatment facilities could be in¯uential for the economic feasibility of various levels of water pollution control programs. However, construction cost estimation is dif®cult to precisely evaluate in an uncertain environment and measured quantities are a
## Abstract This paper demonstrates the usefulness of combining simulation with Bayesian estimation methods in analysis of cost‐effectiveness data collected alongside a clinical trial. Specifically, we use Markov Chain Monte Carlo (MCMC) to estimate a system of generalized linear models relating co